Apple still has a challenge to overcome to bring blood glucose monitoring to market!
He apple watch glucose sensor It is one of the most anticipated updates for the devices. Even the most optimistic reports predicted its arrival with the launch of the Apple Watch in 2025, but a new report says it’s still a long way off.
Information from Mark Gurman’s “Power On” column states that Glucose sensor for Apple Watch, still needs to refine built-in sensors and algorithms to bring the technology to market. And according to the trusted analyst, all of these changes “will take another three to seven years at least,” contradicting his latest posts.
Size does matter
This new publication of Gurman contradicts the report shared just a month ago, in which they claimed that Apple was very close to the final goal. to materialize a monitoring technology that is not invasive on blood glucose, getting ahead of the competition.
At the time, Gurman claimed that Apple was already well ahead in developing a chip technology called “silicon photonics” along with a process of “optical absorption spectroscopy.” It uses lasers that emit wavelengths into an area under the skin where interstitial fluid is present, which can be absorbed by glucose. But while important, this is just one part of the complex process that aims to change blood glucose detection.
However, the size limitations of the Apple Watch represent one of the main obstacles to include additional sensors. According to Gurman, Apple is having trouble shrinking the sensor down to a size that can comfortably fit inside a smartwatch.
The company’s goal is to offer a tool to warn Apple Watch users if they are prediabetic to encourage lifestyle changes before diabetes develops. It is believed to be conducting early discussions on how to obtain regulatory approval for the technology.
According to records, Apple has been conducting trials related to a blood glucose sensor for a decade. The bitten apples began working on this possibility after the acquisition of RareLight in 2010. The company then used a startup called Avolante Health LLC to develop the technology in a secret facility before moving it to the Exploratory Design Group (XDG).